Targeting Plasma Cells in Autoimmune Diseases
Antibodies specific for self-antigens mediate life-threatening pathology in several autoimmune diseases. Clearly the ability to target the plasma cells (PCs) producing the autoantibodies would be of great clinical benefit. Current immunosuppressive therapies are based on the premise that autoreactiv...
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
The Rockefeller University Press
2004
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2211780/ |